Scaling statistical expertise through sustainable tools and training

RPACT as a long-term partner for methodology, software, and capability building

Friedrich Pahlke, Daniel Sabanés Bové, Gernot Wassmer

RPACT

February 12, 2026

Setting the focus for today

  • Building on an established collaboration with Novartis
  • Supporting scalable and sustainable statistical expertise
  • Combining methodology, software, and training
  • Exploring concrete training opportunities for 2026–2028

RPACT - Trusted by leading pharmaceutical companies 📝

  • Long-term collaborations with global pharmaceutical organizations, e.g, Novartis, Pfizer, Roche, Bayer, J&J, Moderna, Gilead, UCB, Merck, …
  • Productive use of our tools in research and regulated environments
  • Trusted partner for methodology, software, validation, and training

A proven partnership with Novartis 🤝

  • Long-term collaboration for almost five years
  • Continuous SLA-based partnership
  • Productive use of rpact and RPACT Cloud
  • Novartis-driven feature development supporting daily workflows
  • Collaboration on various released tools,
    e.g., rpact, rbmi, RPACT Cloud, …
  • Collaboration on various new tools,
    e.g., qtd, covadj, graphical, …

Open source with a long-term commitment

  • Open source as a strategic choice, not an experiment
  • Clear focus on sustainability, validation, and maintainability
  • Reduction of complexity in daily statistical workflows
  • Professional governance with SLA-backed responsibility
  • Continuous evolution driven by real-world user needs

A lean expert organization with clear ownership

RPACT tool ecosystem

A proven ecosystem of production-ready tools

Training formats – concrete and scalable

  • Web-based trainings for broad and efficient knowledge transfer
  • On-site workshops for interactive and advanced topics
  • Role-specific modules (introductory to advanced)
  • Transition from SAS to R (structured onboarding for statisticians and established workflows)
  • Tool-focused and methodology-focused training tracks
  • Designed for short-term needs (2026) and long-term capability building (2028)
  • Backed by a curated set of 30+ practical vignettes and use cases
  • Experience from 80+ presentations and training courses since 2018, including regulatory audiences (FDA)

Executive summary 📝

  • Trusted long-term partner for leading pharmaceutical organizations, incl. Novartis
  • Almost five years of productive collaboration with SLA-backed responsibility
  • Sustainable open-source ecosystem combining methodology, software, and validation
  • High user adoption through usability-focused tools and graphical interfaces
  • Lean expert organization with clear ownership and long-term commitment
  • Proven training expertise, including 80+ trainings since 2018 and a curated set of 30+ practical vignettes
  • Scalable training formats supporting short-term needs (2026) and long-term capability building (2028)